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Abstract  
Nine compounds were isolated and characterized from the culture broth of the marine bacteria Micromonospora 
sp.G019 strain, which was isolated from sediment collecting at Ha Long Bay. Their structures were determined by 
spectroscopic analysis including MS and 2D NMR, as well as by comparison with reported data in the literature. 




Marine microorganisms have been the important 
study in recent years because of production of novel 
metabolites which represent various biological 
properties such as antiviral, antitumor or 
antimicrobial activities. These secondary metabolites 
serve as model systems in discovery of new drugs 
[1, 2]. Metabolites from microorganisms is a rapidly 
growing field, due, at least in part, to the suspicion 
that a number of metabolites obtained from algae 
and invertebrates may be produced by associated 
microorganisms [3]. 
During our biological screening program, the 
extract of Micromonospora sp. G019 had inhibition 
activity against Mycobacterium tuberculosis. The 
present paper deals with the fractionation of the 
EtOAc extract of Micromonospora sp. G019 isolated 
from sediment of the Halong Bay. The purification 
led to the isolation and structural characterization of 




2.1. General Experiment procedures 
 
ESIMS were recorded on an Agilent 1100     
LC-MSD Trap spectrometer. The 
13
C NMR spectra 
were recorded on a Bruker 500.13 MHz 
spectrometer operating at 125.76 MHz, and 
1
H and 
2D NMR spectra were recorded on a Bruker 500.13 
MHz spectrometer operating at 500.13 MHz. 
1
H 
chemical shifts were referenced to CHCl3 and 
CD3OD at 7.26 and 3.33 ppm, respectively, while 
the 
13
C chemical shifts were referenced to the central 
peak of CDCl3 at 77.0 and 49.0 ppm for CD3OD.  
Thin-layer chromatography (TLC) used TLC 
silica gel Merk 60 F254. Column chromatography 
(CC) were carried out on silica gel 40-63 µm or 
Sephadex LH-20. 
 
2.2. Bacteria isolation and fermentation 
 
The marine sediment was collected in Ha Long 
Bay – Quang Ninh on July 2012. The sediment 
sample (1 g) was added to the 10 mL of sterile sea 
water in a conical flask. The flask was agitated for 
about one hour. The marine sediment was filtered and 





dilutions using the sterilized sea water. An aliquot of 
100 μL of each dilution was spread on the media. 
Different media like Starch Casein Agar (SCA), 
Glycerol Asparagine Agar (GA Agar), Humic acid-B 
vitamin agar (HV Agar) and Glucose yeast malt 
extract agar (GYM) were used for isolation of 
actinomycetes. The media containing 50 % of sterile 
sea water were supplemented with rifampicin (5 
μg/mL) and nystatin (25 μg/mL) (Himedia Mumbai) 
to inhibit bacterial and fungal contamination, 
respectively. The petriplates were incubated upto 3 
weeks at 28 °C. The isolated discrete colonies were 
observed and used for identification. The 
fermentation was carried out in 3 L flask using a 
modification of the published method [4]. 
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2.3. Extraction and isolation 
 
Culture broth (30 L) of Micromonospora sp. 
G019 strain was extracted with EtOAc (5 x 15 L).  
The solvent was concentrated under reduced 
pressure. The residue (4.0 g) was subjected to a 
silica gel column chromatography (CC), eluted with 
CH2Cl2/MeOH mixture (0 to 100 % MeOH in 
CH2Cl2) to give 5 fractions. Fraction 2 (350 mg) was 
purified on silica gel CC, eluting with 
CH2Cl2/EtOAc gradient to obtain five subfractions. 
Subfraction 1 (36 mg) was separated by CC on 
Sephadex LH-20 to give compound 1 (6 mg). 
Subfraction 2 (43 mg) was subjected to CC on 
Sephadex LH-20 eluted with MeOH to yield 
compound 9 (5 mg). Subfraction 3 (54 mg) was 
chromatographed by on silica gel column, eluting 
with a mixture of CH2Cl2/acetone (9/1), followed by 
CC on Sephadex to obtain compound 2 (7 mg). 
Fraction 3 (800 mg) was purified by CC on silica gel 
using CH2Cl2/EtOH gradient affording four 
subfractions. Subfraction 1 (200 mg) was purified on 
a silica gel CC (CH2Cl2/EtOH gradient) following 
by  CC on Sephadex (MeOH) to furnish compounds 
3 (8 mg) and 6 (12 mg). Subfraction 2 (250 mg) was 
separated by CC on silica gel (CH2Cl2/EtOH 
gradient) to yield compounds 7 (4 mg) and 5 (3 mg). 
Fraction 4 (900 mg) was purified on a silica gel CC 
(CH2Cl2/MeOH gradient) yielding 4 subfractions. 
Subfraction 4 (200 mg) was subjected to a CC on 
silica gel (CH2Cl2/acetone gradient) to give 
compounds 8 (9 mg) and 4 (12 mg).   
N-(4-hydroxyphenylethyl)propionamide (1): 





(500 MHz, CD3OD): δ (ppm) 1.11 (3H, t, J = 7.5 
Hz, CH3), 2.18 (2H, q, J = 7.5 Hz, CH2CH3), 2.70 
(2H, t, J = 7.5 Hz, CH2-Ar), 3.32 (2H, m, CH2-N), 
6.73 (2H, d, J = 7.0 Hz, H-3, 5), 7.04 (2H, d, J = 7.0 
Hz, H-2, 6); 13C-NMR (125 MHz, CD3OD): δC 
(ppm) 10.5 (CH3), 30.2 (CH2CH3), 35.7 (CH2-Ar), 
42.2 (CH2-NH), 116.2 (CH-2, 6), 130.7 (CH-3,5), 
131.3 (C-4), 156.9 (C-1), 177.0 (C=O). 
N-(4-hydroxyphenylethyl)acetamide (2): 





NMR (500 MHz, CD3OD): δ (ppm) 1.91 (3H, s, 
CH3C=O), 2.69 (2H, t, J = 7.5 Hz, CH2-Ar), 3.35 
(2H, m, CH2-N), 6.75 (2H, d, J = 7.0 Hz, H-3, 5), 
7.02 (2H, d, J = 7.0 Hz, H-2, 6); 13C-NMR (125 
MHz, CD3OD): δC (ppm) 21.9 (CH3), 34.1 (CH2-
Ar), 40.7 (CH2-NH), 114.9 (CH-3, 5), 129.2 (CH-
2,6), 129.6 (C-1), 154.9 (C-4), 171.3 (C=O). 
2’-deoxythymidine (3): Light yellow needles; 




H-NMR (500 MHz, 
CD3OD) δ (ppm) 1.90 (3H, s, CH3-7), 2.27 (2H, m, 
H-2’), 3.75 (1H, dd, J = 3.5, 12.0 Hz, Ha-5’), 3.82 
(1H, dd, J = 3.0, 12.0 Hz, Hb-5’), 3.93 (1H, m, H-
4’), 4.42 (1H, m, H-3’), 6.30 (1H, t, J = 7.0 Hz, H-
1’), 7.83 (1H, s, H-6); 13C- NMR (125 MHz, 
CD3OD) δ(ppm) 12.4 (C-7), 41.2 (C-2’), 62.8        
(C-5’), 72.2 (C-3’), 86.3 (C-1’), 88.8 (C-4’), 111.5 
(C-5), 138.2 (C-6), 152.4 (C-2), 166.4 (C-4). 
2’-deoxyadenosine (4): Amorphous solid; ESI-




H-NMR (500 MHz, 
CD3OD): δ (ppm) 2.43 (1H, m, Ha-2’), 2.84 (1H, m, 
Hb-2’), 3.76 (1H, dd, J = 3.5, 12.5 Hz, Ha-5’), 3.87 
(1H, dd, J = 3.0, 12.5 Hz, H- Hb-5’), 4.09 (1H, m, H-
3’), 4.60 (1H, m, H-4’), 6.45 (1H, dd, J = 6.0, 8.0 
Hz, H-1’),  8.20 (1H, s, H-8), 8.34 (1H, m, H-2); 
13
C-NMR (125 MHz, CD3OD): δC (ppm) 41.6        
(C-2’), 63.6 (C-5’), 73.1 (C-3’), 87.1 (C-4’), 89.9 
(C-1’), 120.8 (C-5), 141.5 (C-8), 149.9 (C-4), 153.6 
(C-2), 157.5 (C-6). 





H-NMR (500 MHz, CD3OD): δ 
(ppm) 3.77 (1H, dd, J = 3.0, 12.5 Hz, Ha-5’), 3.91 
(1H, dd, J = 2.5, 12.5 Hz, H- Hb-5’), 4.19 (1H, m, H-
4’), 4.35 (1H, dd, J = 3.0, 5.0 Hz, H-3’), 4.76 (1H, 
dd, J = 5.0, 6.5 Hz, H-2’), 5.99 (1H, d, J = 6.0 Hz, 
H-1’), 8.20 (1H, s, H-8), 8.32 (1H, s, H-2). 
2’-deoxyuridine (6): Light yellow needle; ESI-




H-NMR (500 MHz, 
CD3OD) δ(ppm) 2.23 (1H, m, Ha-2’), 2.30 (1H, m, 
Hb-2’), 3.74 (1H, dd, J = 3.5, 12.0 Hz, Ha-5’), 3.80 
(1H, dd, J = 3.5, 12.0 Hz, H- Hb-5’), 3.95 (1H, m,   
H-4’), 4.41 (1H, m, H-3’), 5.72 (1H, d, J = 8.0 Hz, 
H-5), 6.28 (1H, t, J = 6.5 Hz, H-1’), 7.99 (1H, d,      
J = 8.0 Hz, H-6); 13C-NMR (125 MHz, CD3OD): δC 
(ppm) 41.3 (C-2’), 62.8 (C-5’), 72.2 (C-3’), 86.6   
(C-4’), 88.9 (C-1’), 102.6 (C-5), 142.5 (C-6), 152.2 
(C-2), 166.6 (C-4). 





H-NMR (500 MHz, CD3OD): δ (ppm) 
3.75 (1H, dd, J = 3.0, 12.5 Hz, Ha-5’), 3.86 (1H, dd, 
J = 2.5, 12.5 Hz, H- Hb-5’), 4.03 (1H, m, H-4’), 4.17 
(1H, m, H-3’), 4.20 (1H, m, H-2’), 5.72 (1H, d, J = 
8.0 Hz, H-5), 5.92 (1H, d, J = 4.5 Hz, H-1’), 8.02 
(1H, d, J = 8.0 Hz, H-6).  





H-NMR (500 MHz, CD3OD): δ (ppm)  
8.13 (1H, s, H-8), 8.20 (1H, s, H-2). 





H-NMR (500 MHz, CD3OD):          
δ (ppm) 1.86 (3H, s, CH3), 7.06 (1H, s,  H-6). 
 
3. RESULTS AND DISCUSSION 
 
Compound 1 was isolated as a white solid. The
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H-NMR spectrum showed 
signals characteristic of an A2B2 aromatic system [δH 
6.73 (2H, d, J = 7.0 Hz, H-3, H-5), 7.04 (2H, d, J = 
7.0 Hz, H-2, H-6)], three methylenes at δH 2.18 (q, J 
= 7.5 Hz, CH2CH3), 2.70 (t, J = 7.5 Hz, CH2-Ar), 
3.32 (m, -CH2-N) and a methyl group at δH 1.11 (t, J 
= 7.5 Hz, CH2CH3). The 
13
C-NMR and DEPT 
spectra of 1 presented the groups observed in the 
1
H-
NMR spectrum with additional signals of a carbonyl 
at δC 177.0 and two sp
2
 quaternary cacbons at δC 
131.3 (C-1) and 156.9 (C-4). The chemical shift of 
C-1 at δC 156.9 indicated its linkage to oxygen while 
those of the methylene at δC 40.7 and δH 3.32 
suggested its connection to nitrogen. Analyses of 2D 
NMR spectra established the structure of 1 as N-(4-
hydroxyphenylethyl)propionamide. The presence of 
amide group was defined by the correlation of the 
carbonyl carbon at δC 177.0 (C-4’) with protons of 
CH2-2’ (δH 3.32) in the HMBC spectrum. The NMR 
data of 1 were in agreement with those previously 
reported [5]. 
Compound 2 was obtained as a white needle. 
The ESI mass spectrum (negative) of 2 showed a 
pseudomolecular ion peak at m/z 178.1 [M-H]
-
 . The 
NMR data of compound 2 showed similar 
spectroscopic features as compound 1. The 
differences between these two compounds were the 
presence of an acetyl instead of the propionyl group. 
The NMR data of 2 were consistent with those 
previously reported for N-(4-hydroxyphenylethyl)-
acetamide [6, 7]. This compound was found to 
exhibit the aldose reductase inhibitory activity with 







Figure 1: Compounds isolated from the broth culture of Micromonospora sp. G019 
 
ESI mass spectrum of 3 presented a 





H-NMR spectrum, compound 3 displayed 
signals of a olefin proton at δH 7.83 (s, H-6), a 
methyl group at δH 1.90 (s, CH3-7) and a set of 
aliphatic protons at δH 2.27 (2H, m, H-2’), 3.75 (1H, 
dd, J = 3.5, 12.0 Hz, Ha-5’), 3.82 (1H, dd, J = 3.0, 
12.0 Hz, Hb-5’), 3.93 (1H, m, H-4’), 4.42 (1H, m, H-
3’), 6.30 (1H, t, J = 7.0 Hz, H-1’). The 13C-NMR 
and DEPT spectra of 3 showed the presence of 10 
carbon atoms, including two carbonyl groups at δC 
152.4 (C-2), 166.4 (C-4), a sp
2
 methine at δC 138.2 
(C-6), a quartenary carbon at δC 111.5 (C-5), a 
methyl group at δC 12.4 (CH3-7), two methylenes at 
δC 41.2  (C-2’) and 62.8 (C-5’), and three methines 
at δC 73.1 (C-3’), 87.1 (C-4’) and 89.9 (C-1’). The 
chemical shifts of CH-3’, CH-4’ and CH2-5’ 
indicated their bonding to oxygens, while those of 
CH-1’ suggesting its connection to both nitrogen and 
oxygen. Complete analysis of NMR spectra and 
comparison with the data reported in the literature 
allowed determing the structure of 3 to be 2’-deoxy-
thymidine [8]. 
Compound 4 was obtained as amorphous solid. 
The ESI mass spectrum of 4 showed a 







C) of compound 4 
displayed signals of the 2-deoxy-arabionoside 
moiety as in the structure of 3. However, in the 
aromatic region, compound 4 demonstrated signals 
corresponding to an adenine moiety [δC 120.8 (C-5), 
δC 141.5, δH 8.20 (CH-8), δC 149.9 (C-4), δC 153.6 
δH 8.34 (CH-2) and δC 157.5 (C-6)]. This 
observation suggesed 4 being a nucleoside. Detailed 
analyses of the NMR spectra, the structure of 4 was 
identified as 2’-deoxyadenosine [9]. 
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Compound 5 was obtained as a white solid. The 
ESI mass spectrum of 5 showed a pseudomolecular 
ion peak at m/z 268.1 [M+H]
+
. The 1D NMR spectra 
of 5 presented signals close to those of 4, except for 
presence of an oxymethine in 5 instead of the 
methylene in 4. Furthermore, the proton H-
1’appeared as a doublet in the 1H NMR spectrum of 
5. Whereas, this proton was a doublet of doublet in 
the 
1
H NMR spectrum of 4. This observation 
strongly suggested that 5 was adenosine. The NMR 
data were in agreement with the reported values for 
adenosine [10]. 
Compound 6 was obtained as a light yellow 
needle. The ESI mass spectrum of 5 showed a 
pseudomolecular ion peak at m/z 229.1 [M+H]
+
. The 
1D NMR spectra of 6 presented signals of the 2-
deoxy-arabionoside moiety as in the structures of 3 
and 4. In the aromatic region of the 
1
H-NMR of 6, 
signals of two doublets were noted at 5.72 (1H, d, J 
= 8.0 Hz, H-5) and 7.99 (1H, d, J = 8.0 Hz, H-6). 
The DEPT spectrum of 6 showed additional signals 
of two carbonyl carbons at 152.2 (C-2) and 166.6 
(C-4). This data suggested the presence of uracil 
moiety. Complete analyses of NMR data indicated 
that compound 6 was 2’-deoxyuridine [9]. 





H-NMR data of 7 showed 
similar spectroscopic features as 6. The differences 
between these two compounds were the presence of 
the arabionoside sugar moiety instead of the 2-
deoxy-arabionoside in 6 which was indicated by the 
absence of a methylene NMR signals and the 
appearance of an oxymethine group. Thus, 
compound 7 was identified as uridine [11]. 
Compounds 8 and 9 were also characterized as 
adenine [11] and thymine [13], respectively. Their 
NMR data were in agreement with those reported in 
the literature. 
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